EyePoint Pharmaceuticals, Inc. (EYPT) has 20 known insider and institutional holders on record. The largest holder is PFIZER INC with 74,483,748 shares. Other notable holders include Eastman Ronald W and Cormorant Asset Management, LP.
Over the last 12 months, insiders have made 43 transactions in EYPT stock — 19 buys (valued at $5.75M) and 8 sells (valued at $1.93M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
EYPT Insider Ownership
Top Holder
PFIZER INC
74,483,748 shares
Buys (12 mo)
19
$5.75M value
Sells (12 mo)
8
$1.93M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Pfizer Inc |
10 Percent Owner |
74,483,748 |
2007-08-29 |
|
| 2 |
Eastman Ronald W |
10 Percent Owner |
8,606,324 |
2018-03-30 |
|
| 3 |
Cormorant Asset Management, Lp |
Other: Former 10% Owner |
8,265,000 |
2025-12-08 |
|
| 4 |
Adage Capital Management, L.p. |
10 Percent Owner |
5,156,299 |
2024-04-22 |
|
| 5 |
Ew Healthcare Partners, L.p. |
10 Percent Owner |
3,490,921 |
2023-09-06 |
|
| 6 |
Finlay Aaron |
Secretary |
750,000 |
2007-10-22 |
|
| 7 |
Price David |
CFO |
300,000 |
2019-06-27 |
|
| 8 |
Woodthorpe Katherine |
Director |
200,000 |
2007-11-29 |
|
| 9 |
Freedman Lori |
See Remarks |
125,000 |
2016-07-25 |
|
| 10 |
Ocumension Therapeutics |
Director |
100,221 |
2024-01-16 |
|
| 11 |
Liu Ye |
Director |
100,221 |
2024-01-16 |
|
| 12 |
Ribeiro Ramiro |
Chief Medical Officer |
85,700 |
2026-01-06 |
|
| 13 |
Ashton Paul |
President & CEO |
80,000 |
2016-03-22 |
|
| 14 |
Blum Leonard M |
See Remarks |
65,000 |
2018-05-16 |
|
| 15 |
Jorn Debora |
EVP, Corp. & Comm'l Dev. |
45,000 |
2017-06-29 |
|
| 16 |
Ando Goran |
Director |
41,500 |
2026-01-06 |
|
| 17 |
Rogers Michael W |
Director |
40,000 |
2019-06-27 |
|
| 18 |
Landis John B. |
Director |
40,000 |
2026-01-06 |
|
| 19 |
Sanders Reginald J. |
Director |
40,000 |
2026-01-06 |
|
| 20 |
Dicicco Wendy F |
Director |
40,000 |
2026-01-06 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-23 |
Duker Jay S. |
President and CEO |
Other (Sell) |
76,766 |
$13.11 |
$1.01M |
| 2026-03-16 |
Duker Jay S. |
President and CEO |
Informative Buy |
1,500 |
$13.15 |
$19.72K |
| 2026-03-02 |
Elston George |
Chief Financial Officer |
Gift (Received) |
5,000 |
- |
- |
| 2026-03-04 |
Ribeiro Ramiro |
Chief Medical Officer |
Informative Sell |
2,438 |
$17.87 |
$43.57K |
| 2026-02-17 |
Ribeiro Ramiro |
Chief Medical Officer |
Informative Sell |
2,437 |
$15.00 |
$36.56K |
| 2026-01-05 |
Ribeiro Ramiro |
Chief Medical Officer |
Informative Sell |
42,544 |
$17.10 |
$727.32K |
| 2026-01-06 |
Duker Jay S. |
President and CEO |
Option Exercise (Sell) |
20,793 |
- |
- |
| 2026-01-06 |
Lurker Nancy |
Director |
Option Exercise (Sell) |
75,133 |
- |
- |
| 2026-01-06 |
Elston George |
Chief Financial Officer |
Option Exercise (Sell) |
15,285 |
- |
- |
| 2026-01-02 |
Sanders Reginald J. |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-03 |
Ribeiro Ramiro |
Chief Medical Officer |
Tax Withholding of RSU |
6,373 |
$17.48 |
$111.4K |
| 2026-01-02 |
Ribeiro Ramiro |
Chief Medical Officer |
RSU Award |
85,700 |
- |
- |
| 2026-01-02 |
Duty Stuart |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-05 |
Duker Jay S. |
President and CEO |
Option Exercise (Sell) |
30,000 |
- |
- |
| 2026-01-03 |
Duker Jay S. |
President and CEO |
Tax Withholding of RSU |
23,447 |
$17.48 |
$409.85K |
| 2026-01-02 |
Duker Jay S. |
President and CEO |
RSU Award |
165,000 |
- |
- |
| 2026-01-02 |
Zaderej Karen L. |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-02 |
Landis John B. |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-05 |
Lurker Nancy |
Director |
Option Exercise (Sell) |
12,666 |
- |
- |
| 2026-01-02 |
Lurker Nancy |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-05 |
Elston George |
Chief Financial Officer |
Option Exercise (Sell) |
15,000 |
- |
- |
| 2026-01-03 |
Elston George |
Chief Financial Officer |
Option Exercise (Sell) |
19,667 |
- |
- |
| 2026-01-02 |
Elston George |
Chief Financial Officer |
RSU Award |
63,000 |
- |
- |
| 2026-01-02 |
Dicicco Wendy F |
Director |
RSU Award |
40,000 |
$17.48 |
$699.2K |
| 2026-01-02 |
Ando Goran |
Director |
RSU Award |
41,500 |
$17.48 |
$725.42K |
